Zhang, Qiang
Bykov, Vladimir J. N. http://orcid.org/0000-0002-7199-8942
Wiman, Klas G. http://orcid.org/0000-0002-7113-524X
Zawacka-Pankau, Joanna
Article History
Received: 31 October 2017
Revised: 24 February 2018
Accepted: 28 February 2018
First Online: 18 April 2018
Change Date: 10 October 2019
Change Type: Correction
Change Details: Since publication of this article, the authors have noticed that there was an error in Fig. 1d, third panel from left, “R273H + 200 μM MQ-H” should be “R273H + 200 μM MQ”. Our corrections do not affect the original conclusions of this paper.
Conflict of Interest
: K.G.W. and V.J.N.B. are co-founders and shareholders of Aprea Therapeutics AB, a company that develops p53-based cancer therapy including APR-246. K.G.W. is a member of its Clinical Advisory Board. Research in the K.G.W. lab has received financial support from Aprea Therapeutics AB. K.G.W. has received a salary from Aprea Therapeutics AB.